Bayer presented impressive development in reconstructing its pharmaceutical business during its virtual Pharma Media Day, with breakthrough innovation in healthcare, helping patients experience conditions that are challenging to treat. Bayer, which has recently settled twenty-five collaboration agreements and acquisitions, is committed to transforming patient health.
“Bayer presented impressive development in reconstructing its pharmaceutical business.“
President of Bayer’s Pharmaceuticals Division and Member of the Board of Management at Bayer AG, Stefan Oelrich, stated: "The biomedical and technological revolution that is transforming healthcare at an unprecedented pace is taking place now. Our company is at the forefront of the wave of innovation in cell and gene therapy as well as digital health. We are driving this transformation and growing our promising development portfolio together with our partners. Our joint goal is to bring breakthrough treatments to patients and make healthcare systems more sustainable in the mid and long-term."